https://doi.org/10.1186/s13045-021-01202-2. PMID: 34736513. PMCID: PMC8567696.

2. Здравоохранение в России, 2021: статистический сборник. М.: Росстат. 2021: 171 с. Доступ: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (дата обращения – 18.03.2024). (Healthcare in Russia, 2021: Statistical collection. Moscow: Federal State Statistics Service (Russia). 2021: 171 pp. URL: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (date of access – 01.03.2024) (In Russ.)).

3. Клинические рекомендации. Железодефицитная анемия. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 669. Доступ: https://cr.minzdrav.gov.ru/schema/669_1 (дата обращения – 01.03.2024). (Clinical guidelines. Iron-deficiency anemia. National Society of Hematology, National Society of Pediatric Hematologists, Oncologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 669. URL: https://cr.minzdrav.gov.ru/schema/669_1 (date of access – 01.10.2023) (In Russ.)).

4. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. United Nations Children’s Fund, United Nations University, World Health Organization. WHO/NHD/01.3. 2001. URL: https://cdn.who.int/media/docs/default-source/2021-dha-docs/ida_assessment_prevention_control.pdf?sfvrsn=fb8c459c_1&download=true (date of access – 01.03.2024).

5. Приходько В.Ю. Железодефицитная анемия – синдром, требующий настороженности врача. Мистецтво лікування. 2011; (5–6): 81–82 (Prikhodko V.Yu. Iron deficiency anemia is a syndrome that requires a doctor’s alertness. Mystetstvo likuvannya = The Art of Healing. 2011; (5–6): 81–82 (In Russ.)).

https://doi.org/10.17116/profmed20232607180.

6. Kassebaum N.J., Jasrasaria R., Naghavi M. et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5): 615–24.

https://doi.org/10.1182/blood-2013-06-508325. PMID: 24297872. PMCID: PMC3907750.

7. WHO. Global nutrition targets 2025: Policy brief series (WHO/NMH/NHD/14.2). Geneva: World Health Organization. 2014. URL: https://www.who.int/publications/i/item/WHO-NMH-NHD-14.2 (date of access – 01.03.2024).

8. D’Adamo C.R., Novick J.S., Feinberg T.M. et al. A food-derived dietary supplement containing a low dose of iron improved markers of iron status among nonanemic iron-deficient women. J Am Coll Nutr. 2018; 37(4): 342–49.

https://doi.org/10.1080/07315724.2018.1427158. PMID: 29533710. PMCID: PMC6089218.

9. Лукина Е.А., Деженкова А.В. Метаболизм железа в норме и при патологии. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2015; 8(4): 355–361. (Lukina E.A., Dezhenkova A.V. Iron metabolism in normal and pathological conditions. Klinicheskaya onkogematologiya. Fundamental’nyye issledovaniya i klinicheskaya praktika = Clinical Oncohematology. Basic Research and Clinical Practice. 2015; 8(4): 355–361 (In Russ.)).

https://doi.org/10.21320/2500-2139-2015-8-4-362-367. EDN: VFZIVT.

10. McLean E., Cogswell M., Egli I. et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009; 12(4): 444–54.

https://doi.org/10.1017/S1368980008002401. PMID: 18498676.

11. Philip K.E.J., Sadaka A.S., Polkey M.I. et al. The prevalence and associated mortality of non-anaemic iron deficiency in older adults: A 14 years observational cohort study. Br J Haematol. 2020; 189(3): 566–72.

https://doi.org/10.1111/bjh.16409. PMID: 32072619. PMCID: PMC7613129.

12. Ивакина С.Н., Нагимова Г.М., Бакиров Б.А., Кудлай Д.А. Анализ применения железосодержащих лекарственных препаратов для лечения анемии в России. Профилактическая медицина. 2021; 24(4): 13–22. (Ivakina S.N., Nagimova G.M., Bakirov B.A., Kudlay D.A. Analysis of the iron-containing drugs’ application for the treatment of anemia in Russia. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine. 2021; 24(4): 13–22 (In Russ.)).

https://doi.org/10.17116/profmed20212404113. EDN: CIMMWZ.

13. Rohner F., Zimmermann M.B., Wegmueller R. et al. Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in Cote d’Ivoire. Br J Nutr. 2007; 97(5): 970–76.

https://doi.org/10.1017/S0007114507665180. PMID: 17381972.

14. McLean E., de Benoist B., Allen L.H. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull. 2008; 29(2 Suppl): S38–51.

https://doi.org/10.1177/15648265080292S107. PMID: 18709880.

15. Wirth J.P., Woodruff B.A., Engle-Stone R. et al. Predictors of anemia in women of reproductive age: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr. 2017; 106(Suppl 1): 416S–427S.

https://doi.org/10.3945/ajcn.116.143073. PMID: 28615262. PMCID: PMC5490645.

16. Dali-Youcef N., Andres E. An update on cobalamin deficiency in adults. QJM. 2009; 102(1): 17–28.

https://doi.org/10.1093/qjmed/hcn138. PMID: 18990719.

17. Khodabandehloo N., Vakili M., Hashemian Z., Zare Zardini H. Determining functional vitamin B12 deficiency in the elderly. Iran Red Crescent Med J. 2015; 17(8): e13138.

https://doi.org/10.5812/ircmj.17(6)2015.13138. PMID: 26430518. PMCID: PMC4585337.

18. Jung S.B., Nagaraja V., Kapur A., Eslick G.D. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: A systematic review and meta-analysis. Intern Med J. 2015; 45(4): 409–16.

https://doi.org/10.1111/imj.12697. PMID: 25583062.

19. Hirschowitz B.I., Worthington J., Mohnen J. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2008; 27(11): 1110–21.

https://doi.org/10.1111/j.1365-2036.2008.03658.x. PMID: 18315582.

20. Yang W., Cai X., Wu H., Ji L. Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: A meta-analysis. J Diabetes. 2019; 11(9): 729–43.

https://doi.org/10.1111/1753-0407.12900. PMID: 30615306.

21. Didangelos T., Karlafti E., Kotzakioulafi E. et al. Vitamin B12 supplementation in diabetic neuropathy: A 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. 2021; 13(2): 395.

https://doi.org/10.3390/nu13020395. PMID: 33513879. PMCID: PMC7912007.

22. Remacha A.F., Sarda M.P., Canals C. et al. Combined cobalamin and iron deficiency anemia: A diagnostic approach using a model based on age and homocysteine assessment. Ann Hematol. 2013; 92(4): 527–31.

https://doi.org/10.1007/s00277-012-1634-8. PMID: 23183879.

23. Yiannikourides A., Latunde-Dada G.O. A short review of iron metabolism and pathophysiology of iron disorders. Medicines (Basel). 2019; 6(3): 85.

https://doi.org/10.3390/medicines6030085. PMID: 31387234. PMCID: PMC6789448.

24. Conway D., Henderson M.A. Iron metabolism. Anaesth Intensive Care. 2019; 20(3): 175–77.

https://doi.org/10.1016/j.mpaic.2019.01.003.

25. Prabhakar E. Iron in cell metabolism and disease. In: M. Zakaria, T. Hassan (Eds.). Iron metabolism – A double-edged sword (Internet). London: IntechOpen. 2022.

https://doi.org/10.5772/intechopen.101908.

26. Saboor M., Zehra A., Hamali H.A., Mobarki A.A. Revisiting iron metabolism, iron homeostasis and iron deficiency anemia. Clin Lab. 2021; 67(3).

https://doi.org/10.7754/Clin.Lab.2020.200742. PMID: 33739032.

27. Nemeth E., Ganz T. Hepcidin – ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021; 22(12): 6493.

https://doi.org/10.3390/ijms22126493. PMID: 34204327. PMCID: PMC8235187.

28. Лукина Е.А., Ледина А.В., Роговская С.И. Железодефицитная анемия: взгляд гематолога и гинеколога. Оптимизируем диагностику и лечебную тактику. РМЖ. Мать и дитя. 2020; 3(4): 248–253. (Lukina E.A., Ledina A.V., Rogovskaya S.I. Iron-deficiencyanemia: A view of hematologist and gynecologist. Optimizing diagnostic and treatment approach. Russkiy meditsisnkiy zhurnal. Mat’ i ditya = Russian Journal of Woman and Child Health. 2020; 3(4): 248–253 (In Russ.)).

https://doi.org/10.32364/2618-8430-2020-3-4-248-253. EDN: UNNELH.

29. Muckenthaler M.U., Rivella S., Hentze M.W., Galy B. A red carpet for iron metabolism. Cell. 2017; 168(3): 344–61.

https://doi.org/10.1016/j.cell.2016.12.034. PMID: 28129536. PMCID: PMC5706455.

30. Billesbolle C.B., Azumaya C.M., Kretsch R.C. et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 2020; 586(7831): 807–11.

https://doi.org/10.1038/s41586-020-2668-z. PMID: 32814342. PMCID: PMC7906036.

31. Guida C., Altamura S., Klein F.A. et al. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood. 2015; 125(14): 2265–75.

https://doi.org/10.1182/blood-2014-08-595256. PMID: 25662334 PMCID: PMC4383800.

32. Shipton M.J, Thachil J. Vitamin B12 deficiency – A 21st century perspective. Clin Med (Lond). 2015; 15(2): 145–50.

https://doi.org/10.7861/clinmedicine.15-2-145. PMID: 25824066. PMCID: PMC4953733.

33. Hasbaoui B.E., Mebrouk N., Saghir S. et al. Vitamin B12 deficiency: Case report and review of literature. Pan Afr Med J. 2021; 38: 237.

https://doi.org/10.11604/pamj.2021.38.237.20967. PMID: 34046142. PMCID: PMC8140678.

34. Nexo E., Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B12 status: Analytical aspects and clinical utility. Am J Clin Nutr. 2011; 94(1): 359S–365S.

https://doi.org/10.3945/ajcn.111.013458. PMID: 21593496. PMCID: PMC3127504.

35. Nexo E., Hvas A.M., Bleie O. et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem. 2002; 48(10): 1768–71. PMID: 12324494.

36. Stover P.J. Physiology of folate and vitamin B12 in health and disease. Nutr Rev. 2004; 62(6 Pt 2): S3–12; discussion S13.

https://doi.org/10.1111/j.1753-4887.2004.tb00070.x. PMID: 15298442.

37. (Brito A., Hertrampf E., Olivares M. et al. Folate, vitamin B12 and human health. Rev Med Chil. 2012; 140(11): 1464–75 (In Spanish)).

https://doi.org/10.4067/S0034-98872012001100014. PMID: 23677195.

38. Волчкова Н.С., Субханкулова С.Ф. Диагностика и лечение анемий в общей врачебной практике: связь с сердечно-сосудистыми заболеваниями. Международный журнал сердца и сосудистых заболеваний. 2022; 10(34): 44–53. (Volchkova N.S., Subkhankulova S.F. Diagnosis and management of anemia in clinical practice and its association with cardiovascular pathology. Mezhdunarodnyy zhurnal serdtsa i sosudistykh zabolevaniy = International Heart and Vascular Disease Journal 2022; 10(34): 44–53 (In Russ.)).

https://doi.org/10.24412/2311-1623-2022-34-44-53. EDN: SBYJSP.

39. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. World Health Organisation. 2011. URL: https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf?sequence=22&isAllowed=y (date of access – 18.03.2024).

40. Клинические рекомендации. Витамин-В12-дефицитная анемия. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 536. Доступ: https://cr.minzdrav.gov.ru/schema/536_2 (дата обращения – 01.03.2024). (Clinical guidelines. Vitamin B12 deficiency anemia. National Society of Hematology, National Society of Pediatric Hematologists, Oncologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 536. URL: https://cr.minzdrav.gov.ru/schema/536_2 (date of access – 01.10.2023) (In Russ.)).

41. Клинические рекомендации. Фолиеводефицитная анемия. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 540. Доступ: https://cr.minzdrav.gov.ru/schema/540_2 (дата обращения – 01.03.2024). (Clinical guidelines. Folate deficiency anemia. National Society of Hematology, National Society of Pediatric Hematologists, Oncologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 540. URL: https://cr.minzdrav.gov.ru/schema/540_2 (date of access – 01.10.2023) (In Russ.)).

42. Hanna-Rivero N., Tu S.J., Elliott A.D. et al. Anemia and iron deficiency in patients with atrial fibrillation. BMC Cardiovasc Disord. 2022; 22(1): 204.

https://doi.org/10.1186/s12872-022-02633-6. PMID: 35508964. PMCID: PMC9066804.

43. Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: A clinical overview. ScientificWorldJournal. 2012; 2012: 846824.

https://doi.org/10.1100/2012/846824. PMID: 22654638. PMCID: PMC3354642.

44. Tolkien Z., Stecher L., Mander A.P. et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS One. 2015; 10(2): e0117383.

https://doi.org/10.1371/journal.pone.0117383. PMID: 25700159. PMCID: PMC4336293.

45. Ba D.M., Ssentongo P., Kjerulff K.H. et al. Adherence to iron supplementation in 22 Sub-Saharan African countries and associated factors among pregnant women: A large population-based study. Curr Dev Nutr. 2019; 3(12): nzz120.

https://doi.org/10.1093/cdn/nzz120. PMID: 31777771. PMCID: PMC6867960.

46. Pasricha S.R., Tye-Din J., Muckenthaler M.U., Swinkels D.W. Iron deficiency. Lancet. 2021; 397(10270): 233–48.

https://doi.org/10.1016/S0140-6736(20)32594-0. PMID: 33285139.

47. Camaschella C. Iron deficiency. Blood. 2019; 133(1): 30–39.

https://doi.org/10.1182/blood-2018-05-815944. PMID: 30401704.

48. Moretti D., Goede J.S., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015; 126(17): 1981–89.

https://doi.org/10.1182/blood-2015-05-642223. PMID: 26289639.

49. Stoffel N.U., Cercamondi C.I., Brittenham G. et al. Iron absorption from oral iron supple-ments given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron- depleted women: Two open-label, randomised controlled trials. Lancet Haematol. 2017; 4(11): e524–e533.

https://doi.org/10.1016/S2352-3026(17)30182-5. PMID: 29032957.

50. Stoffel N.U., von Siebenthal H.K., Moretti D., Zimmermann M.B. Oral iron supplementation in iron-deficient women: How much and how often? Mol Asp Med. 2020; 75: 100865.

https://doi.org/10.1016/j.mam.2020.100865. PMID: 32650997.

51. Stoffel N.U., Zeder C., Brittenham G.M. et al. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020; 105(5): 1232–39.

https://doi.org/10.3324/haematol.2019.220830. PMID: 31413088. PMCID: PMC7193469.

52. Rimon E., Kagansky N., Kagansky M. et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005; 118(10): 1142–47.

https://doi.org/10.1016/j.amjmed.2005.01.065. PMID: 16194646.

53. Cook J.D., Reddy M.B. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr. 2001; 73(1): 93–98.

https://doi.org/10.1093/ajcn/73.1.93. PMID: 11124756.

54. Hurrell R., Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010; 91(5): 1461S–1467S.

https://doi.org/10.3945/ajcn.2010.28674F. PMID: 20200263.

55. Von Siebenthal H.K., Moretti D., Zimmermann M.B., Stoffel N.U. Effect of dietary factors and time of day on iron absorption from oral iron supplements in iron deficient women. Am J Hematol. 2023; 98(9): 1356–63.

https://doi.org/10.1002/ajh.26987. PMID: 37357807.

56. WHO. Weekly iron and folic acid supplementation as an anaemia-prevention strategy in women and adolescent girls lessons learnt from implementation of programmes among non-pregnant women of reproductive age. Geneva: World Health Organization. 2018 (WHO/NMH/NHD/18.8). URL: https://iris.who.int/bitstream/handle/10665/274581/WHO-NMH-NHD-18.8-eng.pdf?sequence=1 (date of access – 01.03.2024).

57. Kharb S., Aggarwal D., Bala J., Nanda S. Evaluation of homocysteine, vitamin B12 and folic acid levels during all the trimesters in pregnant and preeclamptic womens. Curr Hypertens Rev. 2016; 12(3): 234–38.

https://doi.org/10.2174/1573402112666161010151632. PMID: 27748186.

58. Choudhury S., Borah A. Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy. Med Hypotheses. 2015; 85(1): 64–67.

https://doi.org/10.1016/j.mehy.2015.03.027. PMID: 25881985.

59. Moretti R., Caruso P., Dal Ben M. et al. Vitamin D, homocysteine, and folate in subcortical vascular dementia and Alzheimer dementia. Front Aging Neurosci. 2017; 9: 169.

https://doi.org/10.3389/fnagi.2017.00169. PMID: 28611659. PMCID: PMC5447683.

60. Schrott R., Murphy S.K. Folic acid throughout pregnancy: Too much? Am J Clin Nutr. 2018; 107(4): 497–98.

https://doi.org/10.1093/ajcn/nqy055. PMID: 29635510. PMCID: PMC6693531.

61. Borah A. Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy. Med Hypotheses. 2015; 85(1): 64–67.

https://doi.org/10.1016/j.mehy.2015.03.027. PMID: 25881985.

62. Шеманаева Т.В., Воеводин С.М. Роль фолиевой кислоты в профилактике заболеваний нервной системы у плода. Российский вестник акушера-гинеколога. 2015; 15(5): 25–31. (Shemanaeva T.V., Voevodin S.M. Role of folic acid in the prevention of fetal nervous system diseases. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2015; 15(5): 25–31 (In Russ.)).

https://doi.org/10.17116/rosakush201515425-31. EDN: VHUJBV.

63. WHO. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva, World Health Organization. 2012. URL: https://iris.who.int/bitstream/handle/10665/77770/9789241501996_eng.pdf?sequence=1 (date of access – 01.03.2024).

64. Suliburska J., Skrypnik K., Chmurzynska A. Folic acid affects iron status in female rats with deficiency of these micronutrients. Biol Trace Elem Res. 2020; 195(2): 551–58.

https://doi.org/10.1007/s12011-019-01888-z. PMID: 31512172. PMCID: PMC7176598.

65. Государственный реестр лекарственных средств Минздрава России. Листок-вкладыш лекарственного препарата Ферро-Фольгамма Нео®. РУ: ЛП-№(000586)-(РГ-RU) от 17.02.2022. Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e182712d-0eb7-4c4d-803b-f77493178a54 (дата обращения – 01.03.2024). (State register of medicines of the Russian Ministry of Health. Package leaflet for the drug Ferro-Folgamma Neo®. Registration certificate: ЛП-№(000586)-(РГ-RU) dated 02/17/2024. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e182712d-0eb7-4c4d-803b-f77493178a54 (date of access – 01.03.2024) (In Russ.)).

66. Вавилова Т.В., Самоховец В.А., Жиленкова Ю.И. Коррекция дефицита железа и фолиевой кислоты у женщин репродуктивного возраста. Профилактическая медицина. 2024; 27(2): 86–91. (Vavilova T.V., Samokhovets V.A., Zhilenkova Yu.I. Correction of iron and folic acid deficiency in the reproductive age women. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine and Public Health. 2024; 27(2): 86–91 (In Russ.)).

https://doi.org/10.17116/profmed20242702186. EDN: BUCCUY.

67. Andres E., Zulfiqar A.A., Vogel T. State of the art review: Oral and nasal vitamin B12 therapy in the elderly. QJM. 2020; 113(1): 5–15.

https://doi.org/10.1093/qjmed/hcz046. PMID: 30796433.

68. Oh R., Brown D.L. Vitamin B12 deficiency. Am Fam Physician. 2003; 67(5): 979–86. PMID: 12643357.

69. Metaxas C., Mathis D., Jeger C. et al. Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: A randomised parallel-group trial. Swiss Med Wkly. 2017; 147: w14421.

https://doi.org/10.4414/smw.2017.14421. PMID: 28421567.

70. Kuzminski A.M., Del Giacco E.J., Allen R.H. et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998; 92(4): 1191–98. PMID: 9694707.

71. Elia M. Oral or parenteral therapy for B12 deficiency. Lancet. 1998; 352(9142): 1721–22.

https://doi.org/10.1016/S0140-6736(05)79821-4. PMID: 9848344.

72. Castelli M.C., Friedman K., Sherry J. et al. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: A randomized, open-label, parallel-group study. Clin Ther. 2011; 33(3): 358–371.e2.

https://doi.org/10.1016/j.clinthera.2011.03.003. PMID: 21600388.

73. Wang H., Li L., Qin L.L. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018; 3(3): CD004655.

https://doi.org/10.1002/14651858.CD004655.pub3. PMID: 29543316. PMCID: PMC6494183.

74. Sanz-Cuesta T., Gonzalez-Escobar P., Riesgo-Fuertes R. et al.; OB12 Group. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: A pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health. 2012; 12: 394.

https://doi.org/10.1186/1471-2458-12-394. PMID: 22650964. PMCID: PMC3403849.

75. Health Quality Ontario. Vitamin B12 and cognitive function: An evidence-based analysis. Ont Health Technol Assess Ser. 2013; 13(23): 1–45. PMID: 24379897. PMCID: PMC3874776.

76. Andres E., Zulfiqar A.A., Serraj K. et al. Systematic review and pragmatic clinical approach to oral and nasal vitamin B12 (cobalamin) treatment in patients with vitamin B12 deficiency related to gastrointestinal disorders. J Clin Med. 2018; 7(10): 304.

https://doi.org/10.3390/jcm7100304. PMID: 30261596. PMCID: PMC6210286.

77. Gomollon F., Gargallo C.J., Munoz J.F. et al. Oral cyanocobalamin is effective in the treatment of vitamin B12 deficiency in Crohn’s disease. Nutrients. 2017; 9(3): 308.

https://doi.org/10.3390/nu9030308. PMID: 28335526. PMCID: PMC5372971.

78. Nyholm E., Turpin P., Swain D. et al. Oral vitamin B12 can change our practice. Postgrad Med J. 2003; 79(930): 218–20.

https://doi.org/10.1136/pmj.79.930.218. PMID: 12743340. PMCID: PMC1742688.

79. Kwong J.C., Carr D., Dhalla I.A. et al. Oral vitamin B12 therapy in the primary care setting: A qualitative and quantitative study of patient perspectives. BMC Fam Pract. 2005; 6(1): 8.

https://doi.org/10.1186/1471-2296-6-8. PMID: 15723708. PMCID: PMC554115.

80. Abdelwahab O.A., Abdelaziz A., Diab S. et al. Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis. Ir J Med Sci. 2024.

https://doi.org/10.1007/s11845-023-03602-4. PMID: 38231320. Online ahead of print.

81. Andres E., Kurtz J.E., Perrin A.E. et al. Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption. Am J Med. 2001; 111(2): 126–29.

https://doi.org/10.1016/s0002-9343(01)00792-6. PMID: 11498066.

82. Andres E., Henoun Loukili N., Noel E. et al. Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients. Curr Ther Res Clin Exp. 2005; 66(1): 13–22.

https://doi.org/10.1016/j.curtheres.2005.02.001. PMID: 24672108. PMCID: PMC3964566.

83. Butler C.C., Vidal-Alaball J., Cannings-John R. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: A systematic review of randomized controlled trials. Fam Pract. 2006; 23(3): 279–85.

https://doi.org/10.1093/fampra/cml008. PMID: 16585128.

84. Eussen S.J., de Groot L.C., Clarke R., Schneede J. et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: A dose-finding trial. Arch Intern Med. 2005; 165(10): 1167–72.

https://doi.org/10.1001/archinte.165.10.1167. PMID: 15911731.

85. Chan C.Q., Low L.L., Lee K.H. Oral vitamin B12 replacement for the treatment of pernicious anemia. Front Med (Lausanne). 2016; 3: 38.

https://doi.org/10.3389/fmed.2016.00038. PMID: 27602354. PMCID: PMC4993789.

86. Mechanick J.I., Youdim A., Jones D.B. et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient – 2013 update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013; 21 Suppl 1(0–1): S1–27.

https://doi.org/10.1002/oby.20461. PMID: 23529939. PMCID: PMC4142593.

87. Andres E. Oral cobalamin therapy: It may be perhaps time to propose international recommendations? Presse Med. 2012; 41(10): 895–98.

https://doi.org/10.1016/j.lpm.2012.05.001. PMID: 22748272.

88. Bensky M.J., Ayalon-Dangur I., Ayalon-Dangur R. et al. Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency. Drug Deliv Transl Res. 2019; 9(3): 625–30.

https://doi.org/10.1007/s13346-018-00613-y. PMID: 30632091.

89. Parry-Strong A., Langdana F., Haeusler S. et al. Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: A randomised trial. N Z Med J. 2016; 129(1436): 67–75. PMID: 27355231.

90. Kotilea K., Quennery S., Decroes V., Hermans D.A. Successful sublingual cobalamin treatment in a child with short-bowel syndrome. J Pediatr Pharmacol Ther. 2014; 19(1): 60–63.

https://doi.org/10.5863/1551-6776-19.1.60. PMID: 24782694. PMCID: PMC3998971.